NIH Begins Clinical Trial for Universal Flu Vaccine
The National Institutes of Health (NIH) has announced the start of a phase I clinical trial for a potential universal flu vaccine, which uses mRNA technology. The candidate was developed by researchers at the NIH’s National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center. The experimental shot will be compared to a typical…